The goal of the experiment outlined in this article is to improve upon noncemented methods of arthroplasty for clinical application in elderly patients. This was done by determining whether titanium implants with a novel nanostructured zirconia surface, which was created by ion beam–assisted deposition, would prevent impaired osseointegration of intramedullary implants in 1-year-old rats receiving a protein-deficient diet. Specifically, we asked whether the implant with the nanostructured zirconia surface would increase expression of markers of bone maturation within the remodeling of peri-implant woven bone. The control implants, which were made of commercially pure titanium, had a polished surface ex vivo but are known to acquire a microstructured titania surface in vivo. Ten 1-year-old rats received experimental implant (group A) and 10 had control (group B) implants. Ten 3-month-old rats received normal protein diet and the control implant (group C). Animals were euthanized 8 weeks after implantation, and transverse sections of femur-implant samples were used for histology, micro-computed tomography and immunohistochemical evaluations. In group B, the expression of α2β1 and α5β1 integrins, which are known to mediate osteoblast adhesion, glycosaminoglycans, heparan sulfate and chondroitin sulfate, was less than half of that in group C. Important to this study, the zirconia surface used in group A prevented these deficiencies. Therefore, these results indicate that nanostructured zirconia surface created on clinical implants by ion beam–assisted deposition may prevent impaired osseointegration in elderly patients by promoting quicker maturation of peri-implant woven bone.
KurtzSOngKLauE. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am2007; 89(4): 780–785.
2.
MorshedSBozicKJRiesMD. Comparison of cemented and uncemented fixation in total hip replacement: a meta-analysis. Acta Orthop2007; 78(3): 315–326.
3.
MorraM. Biochemical modification of titanium surfaces: peptides and ECM proteins. Eur Cell Mater2006; 12: 1–15.
4.
von der MarkKParkJBauerS. Nanoscale engineering of biomimetic surfaces: cues from the extracellular matrix. Cell Tissue Res2010; 339(1): 131–153.
5.
ChristensonEMAnsethKSvan den BeuckenJJ. Nanobiomaterial applications in orthopedics. J Orthop Res2007; 25(1): 11–22.
6.
GutweinLGWebsterTJ. Increased viable osteoblast density in the presence of nanophase compared to conventional alumina and titania particles. Biomaterials2004; 25(18): 4175–4183.
7.
PriceRLGutweinLGKaledinL. Osteoblast function on nanophase alumina materials: influence of chemistry, phase, and topography. J Biomed Mater Res A2003; 67(4): 1284–1293.
8.
WebsterTJErgunCDoremusRH. Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J Biomed Mater Res2000; 51(3): 475–483.
9.
WebsterTJErgunCDoremusRH. Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials2000; 21(17): 1803–1810.
10.
WebsterTJSchadlerLSSiegelRW. Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin. Tissue Eng2001; 7(3): 291–301.
11.
WebsterTJSiegelRWBiziosR. Osteoblast adhesion on nanophase ceramics. Biomaterials1999; 20(13): 1221–1227.
12.
RoualdesODuclosMEGutknechtD. In vitro and in vivo evaluation of an alumina-zirconia composite for arthroplasty applications. Biomaterials2010; 31(8): 2043–2054.
13.
KakarlapudiRFritzEMollnerT. Transforming growth factor beta 1 accelerates new bone formation after medullary reaming. Trans Annu Meet Orthop Res Soc; 2003Feb2-5; New Orleans, LA. Boston: Orthopaedic Research Society; c2003.
14.
PatelPLanganAJohnsonM. The relationship between vascular endothelial growth factor 164 isoform m RNA expression and bone healing. Trans Annu Meet Orthop Res Soc; 2003Feb2-5; New Orleans, LA. Boston: Orthopaedic Research Society; c2003.
15.
AmselSManiatisATavassoliM. The significance of intramedullary cancellous bone formation in the repair of bone marrow tissue. Anat Rec1969; 164(1): 101–111.
16.
SuvaLJSeedorJGEndoN. Pattern of gene expression following rat tibial marrow ablation. J Bone Miner Res1993; 8(3): 379–388.
17.
ShubayevVIBranemarkRSteinauerJ. Titanium implants induce expression of matrix metalloproteinases in bone during osseointegration. J Rehabil Res Dev2004; 41(6A): 757–766.
18.
YsanderMBranemarkROlmarkerK. Intramedullary osseointegration: development of a rodent model and study of histology and neuropeptide changes around titanium implants. J Rehabil Res Dev2001; 38(2): 183–190.
19.
NamavarFCheungCLSabirianovRF. Lotus effect in engineered zirconia. Nano Lett2008; 8(4): 988–996.
20.
SabirianovRFNamavarFZengXC. Mechanical properties of nanostructured hard coating of ZrO2. MRS Online Proc Libr2009; 1224, 1224-GG06-04; Cambridge University Press31Jan2011.
21.
LianJZhangJNamavarF. Ion beam-induced amorphous-to-tetragonal phase transformation and grain growth of nanocrystalline zirconia. Nanotechnology2009; 20(24): 245303.
ZhangYJiangWWangC. Grain growth and phase stability of nanocrystalline cubic zirconia under ion irradiation. Phys Rev B Condens Matter Mater Phys2010; 82(18): 184105.
26.
DayerRRizzoliRKaelinA. Low protein intake is associated with impaired titanium implant osseointegration. J Bone Miner Res2006; 21(2): 258–264.
27.
LumbersMNewSAGibsonS. Nutritional status in elderly female hip fracture patients: comparison with an age-matched home living group attending day centres. Br J Nutr2001; 85(6): 733–740.
28.
GheriniSVaughnBKLombardiAVJr. Delayed wound healing and nutritional deficiencies after total hip arthroplasty. Clin Orthop Relat Res1993; 293: 188–195.
29.
BranemarkRBranemarkPIRydevikB. Osseointegration in skeletal reconstruction and rehabilitation: a review. J Rehabil Res Dev2001; 38(2): 175–181.
30.
KlingerMMRahemtullaFPrinceCW. Proteoglycans at the bone-implant interface. Crit Rev Oral Biol Med1998; 9(4): 449–463.
31.
MeyerUBuchterAWiesmannHP. Basic reactions of osteoblasts on structured material surfaces. Eur Cell Mater2005; 9: 39–49.
32.
KeselowskyBGWangLSchwartzZ. Integrin alpha(5) controls osteoblastic proliferation and differentiation responses to titanium substrates presenting different roughness characteristics in a roughness independent manner. J Biomed Mater Res A2007; 80(3): 700–710.
33.
Olivares-NavarreteRRazPZhaoG. Integrin alpha2beta1 plays a critical role in osteoblast response to micron-scale surface structure and surface energy of titanium substrates. Proc Natl Acad Sci U S A2008; 105(41): 15767–15772.
IozzoRV. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol1997; 32(2): 141–174.
NurcombeVGohFJHauptLM. Temporal and functional changes in glycosaminoglycan expression during osteogenesis. J Mol Histol2007; 38(5): 469–481.
38.
WaddingtonRJRobertsHCSugarsRV. Differential roles for small leucine-rich proteoglycans in bone formation. Eur Cell Mater2003; 6: 12–21; discussion 21.
39.
BartoldPM. A biochemical and immunohistochemical study of the proteoglycans of alveolar bone. J Dent Res1990; 69(1): 7–19.
40.
BiancoPFisherLWYoungMF. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem1990; 38(11): 1549–1563.
41.
IngramRTClarkeBLFisherLW. Distribution of noncollagenous proteins in the matrix of adult human bone: evidence of anatomic and functional heterogeneity. J Bone Miner Res1993; 8(9): 1019–1029.
42.
SmithAJSinghraoSKNewmanGR. A biochemical and immuno-electron microscopical analysis of chondroitin sulphate-rich proteoglycans in human alveolar bone. Histochem J1997; 29(1): 1–9.
43.
TakagiMMaenoMKagamiA. Biochemical and immunocytochemical characterization of mineral binding proteoglycans in rat bone. J Histochem Cytochem1991; 39(1): 41–50.
44.
TakagiMMaenoMYamadaT. Nature and distribution of chondroitin sulphate and dermatan sulphate proteoglycans in rabbit alveolar bone. Histochem J1996; 28(5): 341–351.
45.
HauptLMMuraliSMunFK. The heparan sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1 cells toward osteogenesis. J Cell Physiol2009; 220(3): 780–791.
46.
ThompsonWRModlaSGrindelBJ. Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone. J Bone Miner Res2011; 26(3): 618–629.
47.
NakamuraHKButzFSaruwatariL. A role for proteoglycans in mineralized tissue-titanium adhesion. J Dent Res2007; 86(2): 147–152.
48.
AndersonJMRodriguezAChangDT. Foreign body reaction to biomaterials. Semin Immunol2008; 20(2): 86–100.
49.
HagaMFujiiNNozawa-InoueK. Detailed process of bone remodeling after achievement of osseointegration in a rat implantation model. Anat Rec (Hoboken)2009; 292(1): 38–47.
50.
JacksonJDSharpJGHaiderH. Preliminary analysis of attachment, survival and growth of bone marrow stromal cells on nanocrystalline hard ceramic coatings. In: RavaglioliAKrajewskiA (eds) Ceramics, cells and tissues: materials for scaffolding of biologically engineered systems—interfaces and interactions on a nanoscale. Rome: Consiglio Nazionale Delle Ricerche, 2006, p.109–118.
Olivares-NavarreteRHyzySLHuttonDL. Direct and indirect effects of microstructured titanium substrates on the induction of mesenchymal stem cell differentiation towards the osteoblast lineage. Biomaterials2010; 31(10): 2728–2735.
53.
SinhaRKTuanRS. Regulation of human osteoblast integrin expression by orthopedic implant materials. Bone1996; 18(5): 451–457.
